Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609635 · ClinicalTrials.gov registry record
Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly
A clinical trial of Respiratory Syncytial Virus Infections, sponsored by West Penn Allegheny Health System.
- Completed
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT00609635 is a study of Respiratory Syncytial Virus Infections that has completed, run by West Penn Allegheny Health System. The registered enrollment target is 300 participants, below the 1,077-participant average among 21 other Respiratory Syncytial Virus Infections trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00609635, a study of Respiratory Syncytial Virus Infections, has completed, sponsored by West Penn Allegheny Health System.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study involves studying the genes that may affect how ill you become during respiratory infection with respiratory syncytial virus (RSV). RSV is a virus that often causes common colds. Cytokines are chemicals that are naturally made by your body. Cytokine levels are increased in some people when they have common colds or wheezing caused by respiratory syncytial virus (RSV). The purpose of this study is to study the genes that may control cytokine levels during infection with RSV in the elderly population.
Conditions Studied
Study Locations (1)
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609635
The ClinicalTrials.gov registry entry for NCT00609635 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,077-participant average among 21 other Respiratory Syncytial Virus Infections trials with a reported enrollment target (72% lower). The listed sponsor is West Penn Allegheny Health System, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Syncytial Virus Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00609635 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00609635 about?
NCT00609635 is a clinical study titled "Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly". This research study involves studying the genes that may affect how ill you become during respiratory infection with respiratory syncytial virus (RSV). RSV is a virus that often causes common colds. Cytokines are chemicals that are naturally made by your body. Cytokine levels are increased in some ...
What is the current status of trial NCT00609635?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2007-11. Estimated completion is 2009-04.
What conditions does trial NCT00609635 study?
This clinical trial studies the following conditions: Respiratory Syncytial Virus Infections.
Who is sponsoring clinical trial NCT00609635?
This trial is sponsored by West Penn Allegheny Health System, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00609635 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Syncytial Virus Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of BLB-201 RSV Vaccine in Infants and Children
RECRUITING · Phase 1
-
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
RECRUITING · Phase 3
-
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
RECRUITING · Phase 2
-
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
RECRUITING · Phase 2
-
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
ACTIVE NOT RECRUITING · Phase 3
-
Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.